Show simple item record

dc.contributor.authorExecutive Board 115
dc.coverage.spatialGenevaen
dc.date.accessioned2012-02-13T14:15:12Z
dc.date.available2012-02-13T14:15:12Z
dc.date.issued2005
dc.identifier.govdocEB115/32
dc.identifier.urihttps://apps.who.int/iris/handle/10665/20227
dc.descriptionExecutive Board 115th session, provisional agenda item 4.9en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subjectAntiretroviral therapyen
dc.subjectPharmaceutical productsen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshDrugs, Genericen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Industryen
dc.subject.meshCommerceen
dc.subject.meshDeveloping Countriesen
dc.titleAntiretrovirals and developing countries: report by the Secretariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifiereconomicsen
dc.subject.meshqualifierlegislation and jurisprudenceen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifiersupply and distributionen
dc.subject.meshqualifiertrendsen
who.relation.languageVersion10665/22366en
who.relation.languageVersion10665/68824en
who.relation.languageVersion10665/25352en
who.relation.languageVersion10665/22279en
who.relation.languageVersion10665/21649en
who.relation.languageVersion10665/20757en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB115
    17-25 January 2005

Show simple item record